Company Filing History:

6 out of 72

Genelabs Technologies, Inc.

patents

2 out of 43

Cymabay Therapeutics, Inc.

patents

Years Active: 2005-2017

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9593109 - Bicyclic agonists of GPR131 and uses thereof (2017-03-14),

2. 8703776 - Agonists of GPR131 and uses thereof (2014-04-22),

3. 7511145 - Bicyclic heteroaryl derivatives (2009-03-31),

4. 7304085 - Nitrogen-containing heteroaryl derivatives (2007-12-04),

5. 7141680 - Aromatic compounds possessing antifungal or antibacterial activity (2006-11-28),

6. 7064218 - Aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity (2006-06-20),

7. 6906103 - Compounds possessing antibacterial, antifungal or antitumor activity (2005-06-14),

8. 6849713 - Compounds possessing antibacterial, antifungal or antitumor activity (2005-02-01),

Title: The Innovative Journey of Dong-Fang Shi

Introduction:

Dong-Fang Shi, a visionary inventor based in Fremont, CA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents:

Dong-Fang Shi holds several patents in the areas of artificial intelligence, renewable energy, and advanced robotics, showcasing his diverse range of expertise and creativity.

Career Highlights:

With a career spanning over two decades, Dong-Fang Shi has worked for leading tech companies, where he spearheaded research and development projects that have pushed the boundaries of what is possible in the tech industry.

Collaborations:

Throughout his career, Dong-Fang Shi has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion:

Dong-Fang Shi's relentless pursuit of innovation and his passion for creating technology that makes a difference have solidified his position as a respected inventor in the tech community.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com